Abstract
Black, green, and white teas are the main commercial teas obtained from buds and leaves of Camellia sinensis (L.). The postharvest processing treatments, together with genotype and growing techniques, may strongly affect the chemical composition of the tea infusion and, thereby, its potential effects on health. Catechins constituted up to 30% of tea leaves dry weight. During fermentation, polyphenols undergo enzymatic oxidation, leading to the formation of condensed polymeric compounds regarded as responsible for the typical organoleptic properties of black tea leaves and related infusions. Scientific studies has been recently focusing on the possibility that tea polyphenols, particularly those of black and green tea, may lead to healthy properties in individuals affected by diseases correlated to metabolic syndrome. In vivo experiments reveal that green and black tea polyphenols may be able to reduce hyperglycemia and insulin resistance. Other works suggest that black tea polymeric products may be effective in decreasing blood cholesterol levels and hypertriacylglycerolemia. To this regard, very few data about white tea, being the rarest and the least handled tea, are available so far. It has been reported that white tea could show higher antioxidative capacity than green tea and to exert in vitro lipolytic activity. Considering the increasing interest towards healthy potential through diet and natural medicaments, the aim of the present review was to overview the nutraceutical potential of polyphenols from tea after various degrees of fermentation.
Keywords: Antimicrobial activity, antioxidant activity, hypoglycemic potential, hypolipidemic potential, nutraceutical potential, post-harvest fermentation, tea polyphenols.
Current Pharmaceutical Biotechnology
Title:Exploring the Nutraceutical Potential of Polyphenols from Black, Green and White Tea Infusions – An Overview
Volume: 16 Issue: 3
Author(s): Gian C. Tenore, Maria Daglia, Roberto Ciampaglia and Ettore Novellino
Affiliation:
Keywords: Antimicrobial activity, antioxidant activity, hypoglycemic potential, hypolipidemic potential, nutraceutical potential, post-harvest fermentation, tea polyphenols.
Abstract: Black, green, and white teas are the main commercial teas obtained from buds and leaves of Camellia sinensis (L.). The postharvest processing treatments, together with genotype and growing techniques, may strongly affect the chemical composition of the tea infusion and, thereby, its potential effects on health. Catechins constituted up to 30% of tea leaves dry weight. During fermentation, polyphenols undergo enzymatic oxidation, leading to the formation of condensed polymeric compounds regarded as responsible for the typical organoleptic properties of black tea leaves and related infusions. Scientific studies has been recently focusing on the possibility that tea polyphenols, particularly those of black and green tea, may lead to healthy properties in individuals affected by diseases correlated to metabolic syndrome. In vivo experiments reveal that green and black tea polyphenols may be able to reduce hyperglycemia and insulin resistance. Other works suggest that black tea polymeric products may be effective in decreasing blood cholesterol levels and hypertriacylglycerolemia. To this regard, very few data about white tea, being the rarest and the least handled tea, are available so far. It has been reported that white tea could show higher antioxidative capacity than green tea and to exert in vitro lipolytic activity. Considering the increasing interest towards healthy potential through diet and natural medicaments, the aim of the present review was to overview the nutraceutical potential of polyphenols from tea after various degrees of fermentation.
Export Options
About this article
Cite this article as:
Tenore C. Gian, Daglia Maria, Ciampaglia Roberto and Novellino Ettore, Exploring the Nutraceutical Potential of Polyphenols from Black, Green and White Tea Infusions – An Overview, Current Pharmaceutical Biotechnology 2015; 16 (3) . https://dx.doi.org/10.2174/1389201016666150118133604
DOI https://dx.doi.org/10.2174/1389201016666150118133604 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy
Current Molecular Medicine Cardiovascular Involvement in Pediatric Systemic Autoimmune Diseases: The Emerging Role of Noninvasive Cardiovascular Imaging
Inflammation & Allergy - Drug Targets (Discontinued) Update on Clinical, Pathophysiological and Therapeutic Aspects in ANCAAssociated Vasculitides
Current Drug Discovery Technologies PPARγ and Early Human Placental Development
Current Medicinal Chemistry Adiponectin, Structure, Function and Pathophysiological Implications in Non-Alcoholic Fatty Liver Disease
Mini-Reviews in Medicinal Chemistry Neuropsychiatric Symptoms in Amnestic Mild Cognitive Impairment: Increased Risk and Faster Progression to Dementia
Current Alzheimer Research Cancer and Virus Leads by HTS, Chemical Design and SEA Data Mining
Current Topics in Medicinal Chemistry Lactoferrin Derived Peptides: Mechanisms of Action and their Perspectives as Antimicrobial and Antitumoral Agents
Mini-Reviews in Medicinal Chemistry Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems
Current Drug Targets Identifying User Suitability in sEMG Based Hand Prosthesis Using Neural Networks
Current Signal Transduction Therapy Cellular Protection and Therapeutic Potential of Tocotrienols
Current Pharmaceutical Design The Potential Protective Effects of Phenolic Compounds against Low-density Lipoprotein Oxidation
Current Pharmaceutical Design Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response
Current Pharmaceutical Design Hsp70s and J Proteins of Plasmodium Parasites Infecting Rodents and Primates: Structure, Function, Clinical Relevance, and Drug Targets
Current Pharmaceutical Design Oxidative and Nitrosative Stress and Immune-inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
Current Neuropharmacology Targeting DNA Associated Processes for Cancer Therapy by the Use of SELEX and Anti-gene Approaches - When Selection Meets Rational Design
Medicinal Chemistry Reviews - Online (Discontinued) Novel Marine-Derived Anti-Cancer Agents
Current Pharmaceutical Design Neural Stem Cell Transplantation and CNS Diseases
CNS & Neurological Disorders - Drug Targets Comparative Studies of the Antioxidant Effects of Cis- and Trans- Resveratrol
Current Medicinal Chemistry Molecular Docking Studies of the Antitumoral Activity and Characterization of New Chalcone
Current Topics in Medicinal Chemistry